Free long-acting injectables for patients with psychosis: A step forward

被引：1
|
作者：
Kong, Ling-zhuo [1 ]
Shen, Yu-ting [1 ]
Zhang, Dan-hua [1 ]
Lai, Jian-bo [1 ,2 ,3 ,4 ,5 ,6 ]
Hu, Shao-hua [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Psychiat, Sch Med, Hangzhou 310003, Peoples R China
[2] Key Lab Mental Disorders Management, Hangzhou 310003, Zhejiang, Peoples R China
[3] Brain Res Inst Zhejiang Univ, Hangzhou 310003, Peoples R China
[4] Zhejiang Engn Ctr Math Mental Hlth, Hangzhou 310003, Peoples R China
[5] Zhejiang Univ, NHC & CAMS Key Lab Med Neurobiol, Sch Brain Sci & Brian Med, Dept Neurobiol,Sch Med, Hangzhou 310003, Peoples R China
[6] Zhejiang Univ, MOE Frontier Sci Ctr Brain Sci & Brain machine Int, Sch Med, Hangzhou 310003, Peoples R China
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2023年 / 83卷
关键词：
Long-acting injectable; Psychosis; Free; PREVALENCE;
D O I：
10.1016/j.ajp.2023.103476
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Improving patient acceptance of maintenance treatment with long-acting injectables
    Potkin, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S617 - S617
  • [22] Risperidone long-acting injectable in patients with a new diagnosis of psychosis
    Parellada, E
    Chrzanowski, W
    Andrezina, R
    Milanova, V
    Glue, P
    Medori, R
    Masiak, M
    EUROPEAN PSYCHIATRY, 2005, 20 : S75 - S76
  • [23] Long-acting antipsychotic injectables in patients under compulsory outpatient treatment: the right to choose
    Pinto, C. Mota
    Klut, C.
    Heitor, M. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S389 - S389
  • [24] Clozapine, Long-Acting Injectables (and Polypharmacy?) Superior in US and International Registries
    Leucht, Stefan
    Tiihonen, Jari
    AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (10): : 888 - 889
  • [25] "Ajudar" - a practice with people with mental disorders treated with long-acting injectables
    Ferreira, M. Cabral
    Magalhaes, C. M.
    Silva, F.
    Basto, F.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [26] Lipid based intramuscular long-acting injectables: Current state of the art
    Wilkinson, Janine
    Ajulo, Damilola
    Tamburrini, Valeria
    Gall, Gwenaelle Le
    Kimpe, Kristof
    Holm, Rene
    Belton, Peter
    Qi, Sheng
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 178
  • [27] Machine learning models to accelerate the design of polymeric long-acting injectables
    Pauric Bannigan
    Zeqing Bao
    Riley J. Hickman
    Matteo Aldeghi
    Florian Häse
    Alán Aspuru-Guzik
    Christine Allen
    Nature Communications, 14 (1)
  • [28] The use of long-acting injectables in early-phase schizophrenia Reply
    Fleischhacker, W. Wolfgang
    Rossum, Inge Winter-van
    Kahn, Rene S.
    LANCET PSYCHIATRY, 2023, 10 (07): : 482 - 483
  • [29] Novel dissolution methods for drug release testing of Long-Acting injectables
    Malavia, Nilesh
    Bao, Quanying
    Burgess, Diane J.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 664
  • [30] Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
    Mahlich, Joerg
    Olbrich, Kerstin
    Wilk, Adrian
    Wimmer, Antonie
    Wolff-Menzler, Claus
    CLINICAL DRUG INVESTIGATION, 2021, 41 (01) : 99 - 113
12345